Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 38 5 IN PLASTIC CONTAINER versus DEXTROSE 5 IN ACETATED RINGER S IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 38 5 IN PLASTIC CONTAINER versus DEXTROSE 5 IN ACETATED RINGER S IN PLASTIC CONTAINER.
DEXTROSE 38.5% IN PLASTIC CONTAINER vs DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a simple sugar that provides caloric support and serves as a source of energy. It increases blood glucose levels, which is essential for cellular metabolism, particularly in the brain and erythrocytes.
Dextrose is a monosaccharide that provides caloric supplementation and serves as a source of glucose for cellular metabolism. Acetate in Ringer's solution is metabolized to bicarbonate, acting as an alkalinizing agent to correct acidosis. The electrolyte composition (sodium, potassium, calcium, chloride, magnesium, acetate) maintains fluid and electrolyte balance.
Intravenous administration. Dose depends on clinical condition; typically 50-100 mL of 38.5% dextrose (19.25-38.5 g glucose) for hypoglycemia. Maximum infusion rate: 0.5 g/kg/h.
Intravenous infusion, typically 1000-2000 mL per 24 hours, rate adjusted based on fluid and electrolyte needs.
None Documented
None Documented
~30 minutes (endogenous glucose turnover; clinical context: continuous infusion required for maintenance as glucose is rapidly metabolized)
Not applicable; dextrose is rapidly metabolized and cleared; functional half-life of infused fluid is about 15–30 minutes via redistribution and renal excretion.
100% renal (excreted as carbon dioxide and water after metabolism; negligible unchanged glucose in urine under normoglycemia; renal threshold ~180 mg/dL)
Renal: >95% as water; acetate and electrolytes are metabolized or excreted renally.
Category C
Category C
IV Fluid
IV Fluid